Systemic silencing of PHD2 causes reversible immune regulatory dysfunction.
Yamamoto A, Hester J, Macklin PS, Kawai K, Uchiyama M, Biggs D, Bishop T, Bull K, Cheng X, Cawthorne E, Coleman ML, Crockford TL, Davies B, Dow LE, Goldin R, Kranc K, Kudo H, Lawson H, McAuliffe J, Milward K, Scudamore CL, Soilleux E, Issa F, Ratcliffe PJ, Pugh CW.
Yamamoto A, et al. Among authors: bishop t.
J Clin Invest. 2019 Jun 4;129(9):3640-3656. doi: 10.1172/JCI124099.
J Clin Invest. 2019.
PMID: 31162141
Free PMC article.